SZSE: 300558 - Betta Pharmaceuticals Co., Ltd.

Yield per half year: -11.05%
Dividend yield: +0.15%
Sector: Healthcare

Share chart Betta Pharmaceuticals Co., Ltd.

Extended chart Simple chart
Financial Markets by TradingView

About Betta Pharmaceuticals Co., Ltd.

Betta Pharmaceuticals Co., Ltd. исследует, разрабатывает, производит и продает лекарства для лечения рака в Китае. Компания предлагает икотиниба гидрохлорид, пероральный ингибитор тирозинкиназы рецептора эпидермального фактора роста, который используется для лечения немелкоклеточного рака легких; и энсартиниба гидрохлорид, ингибитор киназы анапластической лимфомы для лечения немелкоклеточного рака легких. Компания Betta Pharmaceuticals Co., Ltd. была основана в 2003 году, ее штаб-квартира находится в Ханчжоу, Китай.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

ISIN CNE100002DD9
Industry Pharmaceuticals
Sector Health Care
Валюта cny
Валюта отчета cny
Див.доход ао 0.15
Дивиденд ао 0.07
Сайт https://www.bettapharma.com
Цена ао 37.36
Change price per day: -4.89% (39.28)
Change price per week: +1.25% (36.9)
Change price per month: +3.92% (35.95)
Change price per 3 month: -0.506% (37.55)
Change price per half year: -11.05% (42)
Change price per year: -16.81% (44.91)
Change price per 3 year: -65.48% (108.24)
Change price per 5 year: -7.06% (40.2)
Change price per 10 year: 0% (37.36)
Change price per year to date: +17.63% (31.76)
All parameters

Underestimation

Title Value Grade
P/S 8.6 1
P/BV 4.08 4
P/E 177.04 1
EV/EBITDA 89.7 1
Total: 5.75

Efficiency

Title Value Grade
ROA, % 0.6 1
ROE, % 1.91 1
Total: 1.17

Dividends

Title Value Grade
Div yield, % 0.15 0.38
DSI 0.7857 7.86
Total: 2.08

Debt

Title Value Grade
Debt/EBITDA 6.02 0
Total: 6

Growth impulse

Title Value Grade
Yield Revenue, % 58.06 7
Yield Ebitda, % 75.08 8
Yield EPS, % -15.35 0
Total: 6.4
More

ETF Share, % Profitability for 1 year, % Dividends, %
VanEck ChiNext ETF 0.39809 16.57 1.74408
Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF 0.17916 7.16 2.6495
Dimensional Emerging Markets Core Equity 2 ETF 0.00177 15.96 3.34087
Vanguard ESG International Stock ETF 0 6.39 3.07501



Head Job title Payment Year of birth
Mr. Jiang Wan Senior VP, COO & Director N/A 1968 (57 years)
Mr. Lingxi Wu Board Secretary & Head of Chairman Office N/A 1983 (42 years)
Dr. Yinxiang Wang President N/A 1965 (60 years)
Dr. Lieming Ding Founder, Chairman of the Board of Directors, CEO & GM N/A 1963 (62 years)
Mr. Jianxun Fan VP, CFO & Director N/A 1971 (54 years)
Dr. Jiabing Wang Senior VP, Chief Scientific Officer & Director N/A 1963 (62 years)
Dr. Wenxin Xu Senior Director & Head of Immunology N/A
Feng Liu Vice President N/A
Hena Shi Vice President N/A
Ms. Yunyan Hu Vice Director of Novel Drug R & D Center 1962 (63 years)

Address: China, Hangzhou, No. 355 Xingzhong Road - open in Google maps, open in Yandex maps
Website: https://www.bettapharma.com